Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The realm of microfluidics revolves around the intricate science of understanding, controlling, and manipulating fluids within minuscule channels crafted at a microscale level. Within this domain, the burgeoning application and advancement of microfluidic cell isolation technology emerge as a pivotal catalyst driving the growth trajectory of the cell isolation market. This specialized technology tailored for cell isolation within the microfluidic framework holds immense promise, particularly in drug assays and various medical research endeavors.
One of the primary focuses of microfluidic cell isolation technology lies in its application within drug assays. This technology is meticulously designed to cater to the demands of drug testing, particularly when utilizing patient-derived cells like circulating tumor cells. The crux here lies in the need to handle minute sample volumes without compromising the integrity and retention of disease-causing cells. In essence, the technology aims to ensure precise manipulation and isolation of these cells within the microfluidic channels, a crucial aspect in drug testing methodologies.
Furthermore, a notable surge has been witnessed in the development of highly effective technologies dedicated to analyzing single tumor cells and their clusters derived from exceedingly small sample sizes. This upswing in technology aims to facilitate the meticulous examination and study of individual tumor cells and their conglomerates, presenting an opportunity for discerning insights into disease pathology and treatment modalities.
Consequently, the strategic application of cell isolation methodologies through the integration of microfluidic devices presents a window of opportunity for key players within the cell isolation market. Investing in the development and enhancement of microfluidic cell isolation products emerges as a viable prospect, considering the intricate demands and potential breakthroughs promised by this evolving technology.
The integration of cell isolation techniques into microfluidic platforms offers a nuanced approach to addressing intricate challenges within medical research and drug development. By harnessing the capabilities of microfluidics, researchers and industry players seek to refine and elevate the precision and efficiency of cell isolation processes. This refined approach holds potential not only in enhancing the accuracy of drug assays but also in unraveling deeper insights into disease mechanisms and cellular behavior.
The intricacies of microfluidic cell isolation are particularly pivotal in the realm of personalized medicine, where the focus lies on tailoring treatments based on individual patient profiles. This technology serves as a cornerstone in handling and analyzing patient-derived cells, enabling a more comprehensive understanding of disease progression and response to treatments on a personalized level.
Moreover, the convergence of advancements in microfluidics with cell isolation methodologies serves as a fertile ground for innovation. This collaboration paves the way for the development of novel and sophisticated devices dedicated to isolating cells with unprecedented precision, ensuring minimal loss and maximal efficacy in the isolation process.
In essence, the symbiosis between cell isolation methodologies and microfluidic technologies presents a compelling frontier within the broader spectrum of medical research and technology. The strategic integration of these disciplines not only fuels the growth potential of the cell isolation market but also stands at the forefront of revolutionizing drug testing, disease analysis, and personalized medicine. The trajectory of microfluidic cell isolation signifies a realm of untapped potential and promising advancements, beckoning forth an era of transformative breakthroughs in healthcare and scientific inquiry.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Increased opportunities in emerging markets. |
| Market Dynamics | Increased adoption of cell isolation techniques and rising cases of chronic diseases that require clinical trials. |
Cell Isolation Market Highlights:
Global Cell Isolation Market Overview
Cell Isolation Market Size was valued at USD 4.9 Billion in 2022. The Cell Isolation market industry is projected to grow from USD 5.77 Billion in 2023 to USD 21.40 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.80% during the forecast period (2023 - 2032). Increased adoption of cell isolation techniques and rising cases of chronic diseases with a growing geriatric population ly are the key market drivers enhancing the growth of market.
Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review
It was in May 2023 when Beckman Coulter launched a new kind of advanced immunoassay analyzer called DxI 9000 Access. The analyzer is able to run up to 215 tests per hour per square meter (t/h/m2).
For this, Alfa Laval AB has decided on an investment program that implies a capacity expansion project with regard to heat exchangers worth SEK 3.8 billion ($360 million) by February 2023. Alfa Laval is expanding its production capacity for heat exchangers across Sweden, Italy, China and the USA as part of a larger investment program.
For example, Thermo Fisher Scientific launched the new fully-customizable Gibco CTS Xenon Electroporation System, bringing large-scale cell therapy development and clinical manufacturing in line with increasing demand. The Gibco CTS Xenon Electroporation System is a complementary addition to Thermo Fisher Scientific's end-to-end cell therapy solutions. Therefore, such innovations and product launches are likely to propel the growth of the Cell Isolation Market during the forecast period.
Similarly, Applied Cells Inc. and STEMCELL Technologies announced their collaboration in April 2022 aimed at delivering a new high-performance cell separation solution that combines Applied Cells' MARS platform with STEMCELL's EasySep immunomagnetic cell separation kits. This will enable global researchers to automate the isolation process and improve efficiency when handling different sample types, including whole blood, bone marrow, apheresis products, and dissociated tissue. Additionally, STEMCELL’s Cell Isolation reagents will expand on the applicability of the MARS platform by meeting specialized requirements for isolating very rare cancer cells from human samples. Thus, factors such as initiatives by key market players are expected to boost the segment’s growth.
In October 2022, Thermo Fisher Scientific launched a closed and automated cell isolation and bead removal solution to help evolve cell therapy manufacturing. The cell purity, isolation efficiency, and target cell recovery for scalable cell therapy manufacturing have improved with the new technology.
Sony Corporation unveiled CGX10, an advanced cell isolation system that sorts cells at high speed and high purity in a closed system, in January 2022.
Cell Isolation Market Trends
- The growing adoption of cell separation techniques is driving the market growth.
Market CAGR for cell isolation is being driven by the rising adoption of cell separation techniques in the biotechnology and pharmaceutical industries, mainly in developing countries. The technique is well practiced for the development of regenerative medicine, boosting stem cell research. The growing prevalence of the chronic diseases and rising geriatric population is surging the demand for clinical trials and research. The rising productive partnerships in microfluidics are expected to fuel cell isolation technologies ly.
The growing number of chronic diseases like obesity, diabetes, arthritis, cancer, and cardiac diseases are rising owing to the sedentary lifestyle, aging of the population, and growth in the consumption of alcohol and cigarette smoking. The geriatric population is anticipated to suffer from chronic diseases like neurological disorders and cancer more often compared to the younger population, and moreover, there is a rapid growth in the geriatric population. Hence, the geriatric population aged 65 years and above is anticipated to increase the incidence of dementia, cancer, Alzheimer and immune diseases, thus driving the demand for clinical trials and research that requires cell separation products. Technological advancement is encouraging companies to innovate in microfluid cell isolation technology. Strategic collaboration and partnerships are recent trends that are boosting innovation and the development of microfluidics-based products.
The stem cell is an important cell therapy used in the development of regenerative medicine, employed in the replacement of organs or tissues than treating them. The number of biotechnology companies operating throughout the world is rising in developing countries. Pharmaceutical companies are bound to utilize cell isolation techniques to develop drugs and continue contributing to innovation. The stem cells need a substantially higher number of clinical trials, thus boosting the growth of the market. The advancement in the development of drugs and treatments like CAR-T through cell isolation techniques is expected to boost pharmaceutical and biotechnology companies. Thus, driving the Cell Isolation market revenue.
Cell Isolation Market Segment Insights
Cell Isolation Cell Type Insights
The Cell Isolation market segmentation, based on cell type, includes Human Cells and Animal Cells. The animal cells segment dominates the market, accounting for the largest market revenue. The rising emphasis of government, healthcare, and private companies on novel drug discoveries and development is a main factor fueling the growth of the segment. This involves the utilization of animal cells in order to examine the efficiency, the pharmacokinetics of new drug molecules, and the preliminary toxicity. Further, the human cells segment is expected to be the rapid growing segment throughout the forecast period due to rising applications of isolated human cells in biopharmaceutical development; research, and clinical trials are the major factors owing to the growing focus on human & cancer research.
Figure 1 Cell Isolation Market, by Cell Type, 2022 & 2032 (USD Billion)
Source the Secondary Research, Primary Research, MRFR Database, and Analyst Review
Cell Isolation Techniques Insights
The Cell Isolation market segmentation, based on techniques, includes Centrifugation, Surface Marker, and Filtration. The centrifugation segment dominates the market owing to the extensive use of this technique by research laboratories, academic institutes, and biotechnology and pharmaceutical companies. This technique is one of the most crucial steps in the process. Further, the surface marker segment is anticipated to witness significant growth throughout the forecast years owing to the growing investments in manufacturing infrastructure by companies, and product advancements are major factors boosting this segment's growth. The manufacturers are involved in the utilization of modern surfaced markers for production to make sure an improved quality of the end product.
Cell Isolation Regional Insights
By region, the study gives market insights into the North America, Europe, Asia-Pacific, and the Rest of the World. The North American Cell Isolation market area dominates the market owing to the availability of well-established biotech and pharmaceutical industries and the growing adoption of technologically advanced solutions in this region. The extensive research activities by research universities in the field of cell therapies have generated a huge demand for cell isolation solutions in the North American region.
Further, the prime countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil.
Figure 2 THE CELL ISOLATION MARKET SHARE BY REGION 2022 (USD Billion)
Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's Cell Isolation market accounts for the second-largest market share due to growing funding by the government for stem and cancer cell research and the growth of biopharmaceutical & biotechnology industries in this region. Further, the German Cell Isolation market held the largest market share, and the UK Cell Isolation market was the rapid-growing market in European region.
The Asia-Pacific Cell Isolation Market is expected to grow at the rapid CAGR from 2023 to 2032. This is due to the growing biotechnology & pharmaceutical industries in developing economies and, the growth in healthcare expenditure, and the rise in market penetration of main market players in this region. Moreover, China’s Cell Isolation market held the largest market share, and the Indian Cell Isolation market was the rapid-growing market in Asia-Pacific region.
Cell Isolation Key Market Players & Competitive Insights
Leading market players are investing hugely in research and development in order to expand their product lines, which will help the Cell Isolation market grow even more. Market players are also undertaking a variety of strategic activities to spread their footprint, with important market developments including new product launches, higher investments, contractual agreements, mergers and acquisitions, and collaboration with other organizations. To spread and survive in a more competitive and rising market climate, the Cell Isolation industry must offer cost-effective items.
Manufacturing locally to minimize the operational costs is one of the key business tactics utilized by manufacturers in the Cell Isolation industry to benefit clients and increase the market sector. In recent years, the Cell Isolation industry has offered some of the most significant advantages to biotechnology. Major players in the Cell Isolation market, including Thermo Fisher Scientific Inc., Akadeum Life Science Inc., Beckman Coulter, GE Healthcare, Becton Dickinson and Company, Bio-Rad Laboratories Inc, Danaher Corporation, STEMCELL Technologies Inc., PerkinElmer, Inc, Miltenyi Biotec, and others, are attempting to increase market demand by investing in the research and development operations.
Thermo Fisher Scientific Inc. was formed in the year 2006 through the merger of Fisher Scientific and Thermo Electron. The company is an American supplier of life sciences solutions, specialty diagnostics, analytical instruments, laboratory, biotechnology services, and pharmaceutical services. The company manufactures scientific instruments, consumables, and chemicals. The company operates through four segments analytical technologies, specialty diagnostic products, life science solutions, and lab products and services, which include CRO services. In October 2022, a closed and automated cell isolation and bead removal solution was launched by the company in order to help evolve cell therapy manufacturing. The new technology enhances cell purity and isolation efficiency and raises the recovery of target cells for scalable cell therapy manufacturing.
Akadeum Life Science Inc. is the developer of Bio-separation products to facilitate the target cell removal from biological samples. The company is an emerging life science startup located in Ann Arbor, MI, founded in the year 2014. The product of the company is based on buoyancy-activated cell sorting, which utilizes microscopic micro-bubbles to capture target cells and rapidly floats them to the surface of the liquid sample for removal, allowing medical practitioners to utilize those cells for performing downstream testing and analysis with higher efficiency. In May 2023, a new series of products, namely leukoplakia human immune cell isolation and T-cell activation/expansion kits for the research and development of cell therapy. This development will strengthen the Leukopak cell isolation product lines of the company.
Key Companies in the Cell Isolation market include
- Thermo Fisher Scientific Inc.
- Akadeum Life Science Inc.
- Beckman Coulter
- GE Healthcare
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc
- Danaher Corporation
- STEMCELL Technologies Inc.
- PerkinElmer, Inc
- Miltenyi Biotec
Cell Isolation Industry Developments
August 2022 Beckman Coulter, a clinical diagnostics company, has launched ARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test showed 99.9% specificity against 1,400 negative samples and 983% sensitivity at 15-30 days post-symptom onset.
January 2022 Solace Nutrition, is a US-based medical nutrition company, which bought R-Kane Nutritionals' assets for an unknown sum. This asset acquisition allows Solace Nutrition to develop synergy between both the brands, accelerate growth, and create a position in an adjacent nutrition sector. R-Kane Nutritionals is a firm formed in the United States that specializes in high-protein meal replacement products for weight loss.
October 2020 GE Healthcare, with the assistance of a supply arrangement, is now able to sell Serena Bright in the US. The first contrast-improved guided biopsy product in the market, Serena Bright, will help patients and clinicians in the fight against breast cancer.
Cell Isolation Market Segmentation
Cell Isolation Cell Type Outlook
- Human Cells
- Animal Cells
Cell Isolation Techniques Outlook
- Centrifugation
- Surface Marker
- Filtration
Cell Isolation Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
